XML 141 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Commitments and Contingencies (Details Narrative) - USD ($)					3 Months Ended	12 Months Ended
	Mar. 19, 2022	Feb. 15, 2022	Nov. 27, 2018	Aug. 15, 2018	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Reimbursement or royalty paid							$ 0
Contingent payments due						$ 0
Global and BioLife Sciences [Member]
Sale of royalty, percentage		20.00%
Equity Method Investment, Ownership Percentage		20.00%
Royalty Agreement [Member]
Royalty, percentage				50.00%
Royalty Agreement [Member] | Chemia Corporation [Member]
Royalty, percentage				50.00%
Sale of royalty, percentage			5.00%
License Agreement [Member]
Sale of royalty, percentage	5.50%
Development cost, percent	50.00%
Costs Incurred, Development Costs	$ 1,250,000
Development Costs, Period Cost					$ 152,000	200,000	$ 0
Contingent legal fees						$ 0

X

- Definition

Contingent legal fees.

+ References

No definition available.

+ Details

Name:	IMPB_ContingentLegalFees
Namespace Prefix:	IMPB_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Contingent payments due.

+ References

No definition available.

+ Details

Name:	IMPB_ContingentPaymentsDue
Namespace Prefix:	IMPB_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Development cost percent.

+ References

No definition available.

+ Details

Name:	IMPB_DevelopmentCostPercent
Namespace Prefix:	IMPB_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Re imbursement or royalty paid.

+ References

No definition available.

+ Details

Name:	IMPB_ReimbursementOrRoyaltyPaid
Namespace Prefix:	IMPB_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Royalty percentage.

+ References

No definition available.

+ Details

Name:	IMPB_RoyaltyPercentage
Namespace Prefix:	IMPB_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Sale of royalty percentage.

+ References

No definition available.

+ Details

Name:	IMPB_SaleOfRoyaltyPercentage
Namespace Prefix:	IMPB_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Development costs incurred, including capitalized costs and costs charged to expense, in oil and gas activities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 932
-SubTopic 235
-Section 50
-Paragraph 18
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482274/932-235-50-18

+ Details

Name:	us-gaap_CostsIncurredDevelopmentCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The capitalized costs incurred during the period (excluded from amortization) to obtain access to proved reserves and to provide facilities for extracting, treating, gathering and storing the oil and gas.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 932
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-10(c)(7)(ii))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479664/932-10-S99-1

+ Details

Name:	us-gaap_DevelopmentCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481687/323-10-50-3

+ Details

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=IMPB_GlobalAndBioLifeSciencesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=IMPB_RoyaltyAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	dei_LegalEntityAxis=IMPB_ChemiaCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=IMPB_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: